Cynthia Arbeeny
Company: Mitotherapeutix
Job title: CSO
Seminars:
Elucidating the Potential of siRNA Approaches for MASH: The Promise of MITO1041 11:15 am
siRNA therapies can modulate targets that were previously considered un-druggable by conventional small molecule or large molecule approaches A GalNAc-SiRNA therapeutic approach is a novel modality to specifically target a single gene in the liver without impact on non-hepatic tissues, leading to a good safety profileRead more
day: Conference Day 2 Track 1 AM